These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34859378)

  • 41. Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.
    Makkar RR; Blanke P; Leipsic J; Thourani V; Chakravarty T; Brown D; Trento A; Guyton R; Babaliaros V; Williams M; Jilaihawi H; Kodali S; George I; Lu M; McCabe JM; Friedman J; Smalling R; Wong SC; Yazdani S; Bhatt DL; Bax J; Kapadia S; Herrmann HC; Mack M; Leon MB
    J Am Coll Cardiol; 2020 Jun; 75(24):3003-3015. PubMed ID: 32553252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of concomitant aortic regurgitation on early hypoattenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Krajcer Z; Costello B
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):1498-1499. PubMed ID: 33306885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prosthesis Geometrical Predictors of Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement With Intra-Annular Prostheses.
    Rashid HN; Michail M; Ihdayhid AR; Khav N; Tan S; Nasis A; Nicholls SJ; Cameron JD; Gooley RP
    Heart Lung Circ; 2022 May; 31(5):678-684. PubMed ID: 35065896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR.
    Simpson TF; Tuohy CV; Rajotte K; Golwala H; Fuss C; Song HK; Zahr F; Chadderdon SM
    Catheter Cardiovasc Interv; 2021 Feb; 97(3):E411-E417. PubMed ID: 32633055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supra-annular Valve-in-Valve implantation reduces blood stasis on the transcatheter aortic valve leaflets.
    Vahidkhah K; Azadani AN
    J Biomech; 2017 Jun; 58():114-122. PubMed ID: 28511838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy.
    Montalescot G; Redheuil A; Vincent F; Desch S; De Benedictis M; Eltchaninoff H; Trenk D; Serfaty JM; Charpentier E; Bouazizi K; Prigent M; Guedeney P; Salloum T; Berti S; Cequier A; Lefèvre T; Leprince P; Silvain J; Van Belle E; Neumann FJ; Portal JJ; Vicaut E; Collet JP;
    JACC Cardiovasc Interv; 2022 Sep; 15(18):1794-1804. PubMed ID: 36137682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of hypo-attenuated leaflet thickening after transcatheter aortic valve implantation: clinical relevance of hypo-attenuated leaflet thickening volume.
    Karády J; Apor A; Nagy AI; Kolossváry M; Bartykowszki A; Szilveszter B; Simon J; Molnár L; Jermendy ÁL; Panajotu A; Suhai FI; Varga A; Rajani R; Maurovich-Horvat P; Merkely B
    Eur Heart J Cardiovasc Imaging; 2020 Dec; 21(12):1395-1404. PubMed ID: 32756984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medium-Term Follow-Up of Early Leaflet Thrombosis After Transcatheter Aortic Valve Replacement.
    Ruile P; Minners J; Breitbart P; Schoechlin S; Gick M; Pache G; Neumann FJ; Hein M
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1164-1171. PubMed ID: 29929639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Xiong TY; Liao YB; Li YJ; Chen F; Li X; Wang ZJ; Wang X; Ou Y; Li Q; Wei JF; Peng Y; Meng W; Feng Y; Chen M
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):1491-1497. PubMed ID: 32400115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prostheses.
    Rashid HN; Nasis A; Gooley RP; Cameron JD; Brown AJ
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1414-1416. PubMed ID: 30218474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Assessment of Coronary Obstruction During Transcatheter Aortic Valve Replacement: Insights From Post-BASILICA Computed Tomography.
    Kitamura M; Wilde J; Dumpies O; Richter I; Obradovic D; Krieghoff C; Gohmann RF; Majunke N; Desch S; Gutberlet M; Borger M; Marwan M; Thiele H; Holzhey D; Abdel-Wahab M
    JACC Cardiovasc Interv; 2022 Mar; 15(5):496-507. PubMed ID: 35272774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural analysis of regional transcatheter aortic valve underexpansion and its implications for subclinical leaflet thrombosis.
    Qiu D; Azadani AN
    Int J Numer Method Biomed Eng; 2022 Oct; 38(10):e3641. PubMed ID: 36054800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Sinotubular Junction Size on TAVR Leaflet Thrombosis: A Fluid-Structure Interaction Analysis.
    Oks D; Reza S; Vázquez M; Houzeaux G; Kovarovic B; Samaniego C; Bluestein D
    Ann Biomed Eng; 2024 Mar; 52(3):719-733. PubMed ID: 38097896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcatheter aortic valve deployment influences neo-sinus thrombosis risk: An in vitro flow study.
    Madukauwa-David ID; Sadri V; Kamioka N; Midha PA; Raghav V; Oshinski JN; Sharma R; Babaliaros V; Yoganathan AP
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):1009-1016. PubMed ID: 31287238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An in vitro evaluation of turbulence after transcatheter aortic valve implantation.
    Hatoum H; Yousefi A; Lilly S; Maureira P; Crestanello J; Dasi LP
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1837-1848. PubMed ID: 29961588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration.
    Sellers SL; Turner CT; Sathananthan J; Cartlidge TRG; Sin F; Bouchareb R; Mooney J; Nørgaard BL; Bax JJ; Bernatchez PN; Dweck MR; Granville DJ; Newby DE; Lauck S; Webb JG; Payne GW; Pibarot P; Blanke P; Seidman MA; Leipsic JA
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):135-145. PubMed ID: 30448122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Follow-Up of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement.
    Hein M; Schoechlin S; Schulz U; Minners J; Breitbart P; Lehane C; Neumann FJ; Ruile P
    JACC Cardiovasc Interv; 2022 Jun; 15(11):1113-1122. PubMed ID: 35680190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
    Yahagi K; Torii S; Ladich E; Kutys R; Romero ME; Mori H; Kolodgie FD; Popma JJ; Virmani R; Finn AV
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):947-955. PubMed ID: 28895294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aortic sinus flow stasis likely in valve-in-valve transcatheter aortic valve implantation.
    Hatoum H; Moore BL; Maureira P; Dollery J; Crestanello JA; Dasi LP
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):32-43.e1. PubMed ID: 28433356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging Evaluation for the Detection of Leaflet Thrombosis After Transcatheter Aortic Valve Replacement.
    Zhao ZG; Wang MY; Jilaihawi H
    Interv Cardiol Clin; 2018 Jul; 7(3):293-299. PubMed ID: 29983142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.